Wedbush Securities Inc Intercept Pharmaceuticals, Inc. Transaction History

Wedbush Securities Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $161,837 - $280,769	-6,611 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$39.09 - $53.44 $7,466 - $10,207	191 Added 2.98%	6,611 $274,000
Q2 2020 Jul 16, 2020	BUY	$46.7 - $92.04 $299,814 - $590,896	6,420 New	6,420 $308,000
Q1 2020 Apr 17, 2020	SELL	$48.35 - $118.68 $144,566 - $354,853	-2,990 Closed	0 $0
Q4 2019 Jan 16, 2020	SELL	$57.36 - $124.1 $283,702 - $613,798	-4,946 Reduced 62.32%	2,990 $371,000
Q3 2019 Oct 17, 2019	BUY	$58.69 - $80.46 $56,166 - $77,000	957 Added 13.71%	7,936 $527,000
Q2 2019 Aug 01, 2019	BUY	$77.77 - $120.68 $139,208 - $216,017	1,790 Added 34.5%	6,979 $555,000
Q1 2019 Apr 17, 2019	BUY	$91.83 - $120.68 $58,312 - $76,631	635 Added 13.94%	5,189 $580,000
Q4 2018 Jan 31, 2019	BUY	$85.79 - $126.46 $92,653 - $136,576	1,080 Added 31.09%	4,554 $459,000
Q3 2018 Nov 13, 2018	BUY	$88.49 - $127.55 $31,590 - $45,535	357 Added 11.45%	3,474 $439,000
Q2 2018 Aug 03, 2018	SELL	$60.0 - $85.67 $156,300 - $223,170	-2,605 Reduced 45.53%	3,117 $262,000
Q1 2018 May 01, 2018	BUY	$52.72 - $67.25 $2,636 - $3,362	50 Added 0.88%	5,722 $352,000
Q4 2017 Feb 09, 2018	BUY	$58.2 - $72.76 $330,110 - $412,694	5,672	5,672 $331,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.